FERONIA可以控制和氧化介导的男性与女性相互作用
Qiaohong Duan1,2, Ming-Che James Liu1,3, Daniel Kita1,4,5
1Department of Biochemistry and Molecular Biology, University of Massachusetts, Amherst, MA, USA.
Nature
|March 28, 2020
概括
通过控制花粉管的吸引力,FERONIA受体激酶可以防止Arabidopsis中的多种子. 在第一个精子受精卵之后, 它保持特定的细胞壁条件, 并使用氧化来阻断化学吸引剂.
科学领域:
- 植物繁殖
- 细胞信号传输
- 分子生物学
背景情况:
- 性繁殖需要防止多种子症.
- 开花植物使用花粉管来输送精子.
- 已知FERONIA受体激酶有助于精子输送并阻断多精子.
研究的目的:
- 阐明FERONIA防止Arabidopsis多种子的机制.
- 了解FERONIA如何控制雌性配体环境以阻断超数的花粉管.
主要方法:
- 研究了FERONIA在状器官中维护pectin结构的作用.
- 在花粉管到达时分析氧化物的积累.
- 研究了氧化对化学吸引剂LURE1的影响.
主要成果:
- 费罗尼亚对于维护 filiform 器官中的脱果素至关重要.
- 花粉管的到来触发了FERONIA-依赖的氧化积累.
- 氧化物化LURE1,抑制其分泌和受体相互作用,从而减少吸引力.
结论:
- FERONIA 调节受精后的反应以防止多种子症.
- 第一个花粉管的到来改变了卵子不再吸引其他人.
- 这种机制通过改变通过氧化的化学吸引剂信号来确保单次受精.
相关概念视频
Nitric Oxide Signaling Pathway
6.0K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.0K
Antianginal Drugs: Nitrates and β-Blockers
1.2K
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.2K
Hormonal Regulation of the Menstrual Cycle
1.3K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
1.3K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
968
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
968
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
454
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
454
Hormonal Control of the Ovarian Cycle
6.2K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
6.2K


